Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
H&D Wireless Sweden Holding B | HDWB | 23. dec 2024 | 0.00 | +5.56 |
H&M B | HMB | 23. dec 2024 | 149.00 | -1.26 |
HAKI Safety A | HAKIA | 23. dec 2024 | 26.00 | +4.00 |
HAKI Safety B | HAKIB | 23. dec 2024 | 23.30 | -0.43 |
Hamlet BioPharma AB (publ) | HAMLETB | 23. dec 2024 | 3.91 | +10.14 |
Hansa Biopharma | HNSA | 23. dec 2024 | 37.50 | -3.55 |
Hanza AB | HANZA | 23. dec 2024 | 75.20 | -1.31 |
Harm Reduction Group | NOHARM | 23. dec 2024 | 0.03 | -15.33 |
Havsfrun Investment | HAVS | 23. dec 2024 | 12.60 | +2.44 |
Havsfrun Investment B | HAVB | 23. dec 2024 | 12.60 | +2.44 |
Haypp Group | HAYPP | 23. dec 2024 | 60.80 | -4.40 |
Headsent | VIMAB | 23. dec 2024 | 10.40 | +7.77 |
Heba B | HEBAB | 23. dec 2024 | 32.15 | -1.68 |
Hedera Group | HEGR | 23. dec 2024 | 2.84 | -2.07 |
Heimstaden Pref | HEIMPREF | 23. dec 2024 | 15.42 | +0.52 |
Heliospectra | HELIO | 23. dec 2024 | 0.40 | -0.25 |
Hemnet Group | HEM | 23. dec 2024 | 334.60 | +1.64 |
Hemply Balance | HMPLY | 23. dec 2024 | 0.04 | -13.33 |
Hernö Gin B | HERNOB | 23. dec 2024 | 3.63 | +4.47 |
Hexagon B | HEXAB | 23. dec 2024 | 105.70 | +0.14 |
Hexagon Purus | HPURO | 23. dec 2024 | 5.39 | +3.85 |
Hexatronic Group | HTRO | 23. dec 2024 | 36.24 | +2.40 |
Hexicon | HEXI | 23. dec 2024 | 0.15 | -2.95 |
Hexpol B | HPOLB | 23. dec 2024 | 102.60 | -0.39 |
Hifab B | HIFAB | 23. dec 2024 | 3.06 | -1.92 |
High Coast Distillery B | HIGHCOB | 23. dec 2024 | 44.80 | 0.00 |
Hilbert | HILBB | 23. dec 2024 | 5.40 | +2.66 |
HMS Networks | HMS | 23. dec 2024 | 439.20 | +2.14 |
Hoegh Autoliners ASA | HAUTOO | 23. dec 2024 | 110.50 | +4.25 |
Hoi Publishing AB | HOIB | 23. dec 2024 | 0.18 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.